Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.54 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.45 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.45 |
| ▸ | GGT1 | P19440 | 2/20 | 0.44 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.44 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14677435 | 1.00 | SLC7A5 (0.54) | SLC7A5SLC1A1FOLH1SLC1A3SLC1A2 | |
| SCHEMBL5704713 | 1.00 | SLC7A5 (0.54) | SLC7A5SLC1A1FOLH1SLC1A3SLC1A2 | |
| SCHEMBL609262 | 1.00 | SLC7A5 (0.54) | SLC7A5SLC1A1FOLH1SLC1A3SLC1A2 | |
| SCHEMBL13224565 | 1.00 | SLC7A5 (0.54) | SLC7A5SLC1A1FOLH1SLC1A3SLC1A2 | |
| SCHEMBL13746294 | 1.00 | SLC7A5 (0.54) | SLC7A5SLC1A1FOLH1SLC1A3SLC1A2 | |
| SCHEMBL502878 | 1.00 | SLC7A5 (0.54) | SLC7A5SLC1A1FOLH1SLC1A3SLC1A2 | |
| SCHEMBL3471145 | 1.00 | SLC7A5 (0.54) | SLC7A5SLC1A1FOLH1SLC1A3SLC1A2 | |
| SCHEMBL13224526 | 1.00 | SLC7A5 (0.54) | SLC7A5SLC1A1FOLH1SLC1A3SLC1A2 | |
| SCHEMBL502879 | 1.00 | SLC7A5 (0.54) | SLC7A5SLC1A1FOLH1SLC1A3SLC1A2 | |
| SCHEMBL12900073 | 0.85 | SLC7A5 (0.50) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| EP-1303258-B1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2006-10-11 | — | — | EP | disclosed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | disclosed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | disclosed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | disclosed |